Endurance Wealth Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 611 |
|
|
2023
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 607 |
|
|
2022
Q4 | $3K | Hold |
300
| – | – | ﹤0.01% | 570 |
|
|
2022
Q3 | $4K | Hold |
300
| – | – | ﹤0.01% | 533 |
|
|
2022
Q2 | $4K | Hold |
300
| – | – | ﹤0.01% | 547 |
|
|
2022
Q1 | $6K | Hold |
300
| – | – | ﹤0.01% | 550 |
|
|
2021
Q4 | $7K | Hold |
300
| – | – | ﹤0.01% | 534 |
|
|
2021
Q3 | $18K | Hold |
300
| – | – | ﹤0.01% | 468 |
|
|
2021
Q2 | $8K | Hold |
300
| – | – | ﹤0.01% | 541 |
|
|
2021
Q1 | $12K | Sell |
300
-200
| -40% | -$8K | ﹤0.01% | 513 |
|
|
2020
Q4 | $24K | Hold |
500
| – | – | ﹤0.01% | 401 |
|
|
2020
Q3 | $16K | Hold |
500
| – | – | ﹤0.01% | 427 |
|
|
2020
Q2 | $11K | Buy |
+500
| New | +$11K | ﹤0.01% | 457 |
|